152 related articles for article (PubMed ID: 12791415)
1. Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release.
Marchais H; Cayzeele G; Legendre JY; Skiba M; Arnaud P
Eur J Pharm Sci; 2003 Jun; 19(2-3):129-32. PubMed ID: 12791415
[TBL] [Abstract][Full Text] [Related]
2. The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules.
Meyer MC; Straughn AB; Mhatre RM; Hussain A; Shah VP; Bottom CB; Cole ET; Lesko LL; Mallinowski H; Williams RL
Pharm Res; 2000 Aug; 17(8):962-6. PubMed ID: 11028942
[TBL] [Abstract][Full Text] [Related]
3. Influence of enzymes and surfactants on the disintegration behavior of cross-linked hard gelatin capsules during dissolution.
Pennings FH; Kwee BL; Vromans H
Drug Dev Ind Pharm; 2006 Jan; 32(1):33-7. PubMed ID: 16455602
[TBL] [Abstract][Full Text] [Related]
4. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance.
Digenis GA; Gold TB; Shah VP
J Pharm Sci; 1994 Jul; 83(7):915-21. PubMed ID: 7965669
[TBL] [Abstract][Full Text] [Related]
5. Towards a universal dissolution medium for carbamazepine.
El-Massik MA; Abdallah OY; Galal S; Daabis NA
Drug Dev Ind Pharm; 2006 Aug; 32(7):893-905. PubMed ID: 16908426
[TBL] [Abstract][Full Text] [Related]
6. The effect of cross-linking on the in vivo disintegration of hard gelatin capsules.
Brown J; Madit N; Cole ET; Wilding IR; Cadé D
Pharm Res; 1998 Jul; 15(7):1026-30. PubMed ID: 9688055
[TBL] [Abstract][Full Text] [Related]
7. Enzymes in the dissolution testing of gelatin capsules.
Marques MR
AAPS PharmSciTech; 2014 Dec; 15(6):1410-6. PubMed ID: 24942315
[TBL] [Abstract][Full Text] [Related]
8. Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity.
Ofner CM; Zhang YE; Jobeck VC; Bowman BJ
J Pharm Sci; 2001 Jan; 90(1):79-88. PubMed ID: 11064381
[TBL] [Abstract][Full Text] [Related]
9. Development of a two-step tier-2 dissolution method for blinded overencapsulated erlotinib tablets using UV fiber optic detection.
Lu X; Xiao B; Lo L; Bolgar MS; Lloyd DK
J Pharm Biomed Anal; 2011 Aug; 56(1):23-9. PubMed ID: 21620602
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture.
Digenis GA; Sandefer EP; Page RC; Doll WJ; Gold TB; Darwazeh NB
Pharm Res; 2000 May; 17(5):572-82. PubMed ID: 10888309
[TBL] [Abstract][Full Text] [Related]
11. Effect of sodium lauryl sulfate in dissolution media on dissolution of hard gelatin capsule shells.
Zhao F; Malayev V; Rao V; Hussain M
Pharm Res; 2004 Jan; 21(1):144-8. PubMed ID: 14984269
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the Dissolution Stability of Hard Gelatin Capsules Using Activated Carbon as a Packaging Component.
Likar MD; Carroll SC; Colgan ST; Yeoh T; MacDonald BC; Johnson GM; Space JS
J Pharm Sci; 2018 Dec; 107(12):3080-3088. PubMed ID: 30145210
[TBL] [Abstract][Full Text] [Related]
13. Retarded dissolution of ibuprofen in gelatin microcapsule by cross-linking with glutaradehyde.
Yong CS; Li DX; Oh DH; Kim JA; Yoo BK; Woo JS; Rhee JD; Choi HG
Arch Pharm Res; 2006 Jun; 29(6):520-4. PubMed ID: 16833022
[TBL] [Abstract][Full Text] [Related]
14. Determination of extent of formaldehyde-induced crosslinking in hard gelatin capsules by near-infrared spectrophotometry.
Gold TB; Buice RG; Lodder RA; Digenis GA
Pharm Res; 1997 Aug; 14(8):1046-50. PubMed ID: 9279887
[TBL] [Abstract][Full Text] [Related]
15. In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers.
Lake OA; Olling M; Barends DM
Eur J Pharm Biopharm; 1999 Jul; 48(1):13-9. PubMed ID: 10477323
[TBL] [Abstract][Full Text] [Related]
16. Microencapsulation of chlorpheniramine maleate-resin particles with crosslinked chitosan for sustained release.
Huang RG; Schwartz JB; Ofner CM
Pharm Dev Technol; 1999 Jan; 4(1):107-15. PubMed ID: 10027219
[TBL] [Abstract][Full Text] [Related]
17. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
Strauch S; Jantratid E; Dressman JB
J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
[TBL] [Abstract][Full Text] [Related]
18. Discriminatory dissolution method for quality control measurements of carbamazepine immediate release tablets based on in vitro--in vivo investigations.
Xu C; Zou M; Wang Y; Liu Y; Yan J; Wu Y; Cheng G
Drug Dev Ind Pharm; 2012 Jun; 38(6):679-88. PubMed ID: 21988132
[TBL] [Abstract][Full Text] [Related]
19. Intestinal delivery of encapsulated bacteriocin peptides in cross-linked alginate microcapsules.
Wei L; Wong D; Jeoh T; Marco ML
Food Res Int; 2024 Jul; 188():114473. PubMed ID: 38823837
[TBL] [Abstract][Full Text] [Related]
20. Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires.
Galal S; El Massik MA; Abdallah OY; Daabis NA
Drug Dev Ind Pharm; 2004 Sep; 30(8):817-29. PubMed ID: 15521328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
